Government halts research on dangerous airborne pathogens

The White House is temporarily shutting down biomedical research on certain infectious diseases, such as MERS, SARS and pandemic flu strains, following several embarrassing safety incidents at government labs. The Obama administration said it will halt funding for studies that deal with risky airborne pathogens. In the interim, the federal government is launching an investigation into the potential risks and benefits associated with such studies. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.